0

Journal Articles

in Endocrinology
 101-120 of 511 Articles
Letters |  August 11, 2010
B-Vitamin Therapy for Diabetic Nephropathy
Iefke Drion, MD
JAMA. 2010;304(6):636-637. doi:10.1001/jama.2010.1104.
Original Contribution |  August 11, 2010 FREE
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Xinzhi Zhang, MD, PhD; Jinan B. Saaddine, MD, MPH; Chiu-Fang Chou, DrPH; et al.
JAMA. 2010;304(6):649-656. doi:10.1001/jama.2010.1111.
Editorial |  July 28, 2010
Rosiglitazone and the Case for Safety Over Certainty
David N. Juurlink, MD, PhD
JAMA. 2010;304(4):469-471. doi:10.1001/jama.2010.954.
Original Contribution |  July 28, 2010 FREE
Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
David J. Graham, MD, MPH; Rita Ouellet-Hellstrom, PhD; Thomas E. MaCurdy, PhD; et al.
JAMA. 2010;304(4):411-418. doi:10.1001/jama.2010.920.
INCLUDES: , Supplemental Content
JAMA Patient Page |  July 14, 2010 FREE
Kidney Failure
Lise M. Stevens, MA; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2010;304(2):228. doi:10.1001/jama.304.2.228.
INCLUDES: , Supplemental Content
Original Contribution |  July 07, 2010 FREE
Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease
Rhonda M. Cooper-DeHoff, PharmD, MS; Yan Gong, PhD; Eileen M. Handberg, PhD; et al.
JAMA. 2010;304(1):61-68. doi:10.1001/jama.2010.884.
Original Contribution |  June 23, 2010 FREE
Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults
Mary L. Biggs, PhD; Kenneth J. Mukamal, MD; Jose A. Luchsinger, MD; et al.
JAMA. 2010;303(24):2504-2512. doi:10.1001/jama.2010.843.
Medical News & Perspectives |  June 16, 2010
Critics Press FDA to Act on Evidence of Rosiglitazone’s Cardiac Safety Issues
Mike Mitka
JAMA. 2010;303(23):2341-2342. doi:10.1001/jama.2010.788.
Commentary |  June 09, 2010
Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
Irl B. Hirsch, MD; Michael Brownlee, MD
JAMA. 2010;303(22):2291-2292. doi:10.1001/jama.2010.785.
Commentary |  May 26, 2010
Balancing Hypoglycemia and Glycemic Control:  A Public Health Approach for Insulin Safety
Leonard Pogach, MD, MBA; David Aron, MD, MS
JAMA. 2010;303(20):2076-2077. doi:10.1001/jama.2010.655.
Medical News & Perspectives |  May 05, 2010
Aggressive Lipid, Hypertension Targeting Yields No Benefit for Some With Diabetes
Mike Mitka
JAMA. 2010;303(17):1681-1683. doi:10.1001/jama.2010.492.
Original Contribution |  April 28, 2010 FREE
Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy:  A Randomized Controlled Trial
Andrew A. House, MD; Misha Eliasziw, PhD; Daniel C. Cattran, MD; et al.
JAMA. 2010;303(16):1603-1609. doi:10.1001/jama.2010.490.
INCLUDES: , Supplemental Content
The Rational Clinical Examination |  April 21, 2010
Does This Patient With Diabetes Have Large-Fiber Peripheral Neuropathy?
Jamil N. Kanji, MD; Rebecca E. S. Anglin, MD; Dereck L. Hunt, MD, MSc, FRCPC; et al.
JAMA. 2010;303(15):1526-1532. doi:10.1001/jama.2010.428.
INCLUDES: CME , Supplemental Content
The World in Medicine |  April 21, 2010
Diabetes Surging in China
Joan Stephenson, PhD
JAMA. 2010;303(15):1470. doi:10.1001/jama.2010.476.
Clinical Review |  April 14, 2010 FREE
Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
Olivia J. Phung, PharmD; Jennifer M. Scholle, PharmD; Mehak Talwar, BS; et al.
JAMA. 2010;303(14):1410-1418. doi:10.1001/jama.2010.405.
INCLUDES: CME , Supplemental Content
Commentary |  April 07, 2010
The Challenge of Multiple Comorbidity for the US Health Care System
Anand K. Parekh, MD, MPH; Mary B. Barton, MD, MPP
JAMA. 2010;303(13):1303-1304. doi:10.1001/jama.2010.381.
Commentary |  March 24, 2010
Setting the RECORD Straight
Steven E. Nissen, MD
JAMA. 2010;303(12):1194-1195. doi:10.1001/jama.2010.333.
Editorial |  March 24, 2010
Ensuring Integrity in Industry-Sponsored Research:  Primum Non Nocere, Revisited
Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2010;303(12):1196-1198. doi:10.1001/jama.2010.337.
Medical News & Perspectives |  March 24, 2010
Aggressive Glycemic Control Might Not Be Best Choice for All Diabetic Patients
Mike Mitka
JAMA. 2010;303(12):1137-1138. doi:10.1001/jama.2010.298.
Original Contribution |  March 24, 2010 FREE
Nephrology Visits and Health Care Resource Use Before and After Reporting Estimated Glomerular Filtration Rate
Brenda R. Hemmelgarn, MD, PhD; Jianguo Zhang, MSc; Braden J. Manns, MD, MSc; et al.
JAMA. 2010;303(12):1151-1158. doi:10.1001/jama.2010.303.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 15, 2013
Factors That Influence Parathyroid Hormone Half-life:  Determining if New Intraoperative Criteria Are Needed
Andrew J. Leiker, BS; Tina W. F. Yen, MD, MS; Dan C. Eastwood, MS; et al.
JAMA Surgery
Invited Critique  |  May 15, 2013
Intraoperative Parathyroid Hormone Criteria: The Quest for Perfection:  Comment on “Factors That Influence Parathyroid Hormone Half-life”
Kelly L. McCoy, MD; Sally E. Carty, MD
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Correction  |  May 13, 2013
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems